Pin1 null mice exhibit low bone mass and attenuation of BMP signaling

Zhong-Jian Shen1, Jie Hu, Aktar Ali

  • 1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America. zhong.shen@UTSouthwestern.edu

Plos One
|May 16, 2013
PubMed

Insights

The peptidyl-prolyl isomerase PIN1 regulates osteoblast activity. Pin1 deficiency impairs bone formation by affecting BMP signaling and key gene expression, revealing PIN1 as a therapeutic target for bone diseases.

Area of Science:

  • Molecular biology
  • Bone biology
  • Biochemistry

Background:

  • Bone remodeling involves osteoblasts and osteoclasts.
  • Molecular mechanisms of osteoblast function are not fully understood.

Purpose of the Study:

  • To investigate the role of peptidyl-prolyl isomerase PIN1 in osteoblast function.
  • To identify PIN1 as a potential therapeutic target for bone diseases.

Main Methods:

  • Analysis of Pin1 null mice.
  • Assessment of bone mineral density and bone formation.
  • Investigation of BMP signaling pathways.
  • Examination of osteoblast-specific gene expression and extracellular matrix production.

Main Results:

  • Pin1 null mice showed decreased bone mineral density and trabecular bone formation.
  • Osteoblasts from Pin1 null mice had impaired BMP signaling.
  • PIN1 interacted with SMAD5 and was essential for osteoblast-specific gene expression (CBFA1, OSX), ECM production (collagen I, OCN), and bone nodule formation.

Conclusions:

  • PIN1 is a critical regulator of osteoblast osteogenic activity.
  • PIN1 controls bone formation through BMP signaling and transcription factor expression.
  • Targeting PIN1 may offer a novel therapeutic strategy for bone diseases.

Related Concept Videos